Labiotech.eu

News and Trends 30 Oct 2020

Bayer’s AskBio Acquisition Strong Statement For Gene Therapy in Europe

This week, German big pharma Bayer announced a €3.5B takeover of Asklepios BioPharmaceutical, a well known US gene therapy specialist. This is only one of many examples of the funding windfall experienced by the gene therapy field in 2020. Despite the difficulties posed by the Covid-19 pandemic, 2020 has been a good year for gene […]

October 30, 2020 - 6 minutesmins - By Helen Albert

News and Trends 29 Oct 2020

Universal Flu Vaccines Yield Second Clinical Failure This Year

In a blow to hopes for better protection from seasonal flu, last week’s phase III failure of BiondVax’s universal flu vaccine follows the phase II flop of Vaccitech’s flu vaccine in January. Last week proved a major setback for the Israeli biotech BiondVax. The company’s vaccine — designed to protect against multiple strains of flu […]

October 29, 2020 - 5 minutesmins - By Jonathan Smith

Interview 28 Oct 2020

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks, such as long timelines and serious adverse reactions. As CEO of the Dutch biotech Kiadis Pharma, Arthur Lahr has been leading the development of a technology that could overcome these limitations by using natural killer […]

October 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

Expert Advice 26 Oct 2020

How to Prepare for a Successful Biotech IPO

Any biotech company that has reached a certain size and is in need of investment will have to consider the critical question: is it time to go public? Navigating the stock market can be particularly challenging for biotech companies. The biotech industry has some unique requirements that sets it apart from, say, tech or real […]

October 26, 2020 - 10 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 19 Oct 2020

Top 10 Companies Combining AI and Drug Discovery in Europe

Rapid advances in artificial intelligence over the last decade have the potential to revolutionize how drugs are developed. These are the top 10 companies in Europe that are working to make AI drug discovery a reality. Drug development is a slow and increasingly expensive process. Artificial intelligence (AI) has the potential to make the drug […]

October 19, 2020 - 8 minutesmins - By Helen Albert

News and Trends 15 Oct 2020

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest company to tackle the rare condition neuromyelitis optica, for which three therapies have been approved in less than a year. Neuromyelitis optica spectrum disorders, previously also known as Devic disease, affect up to 2 in 100,000 people around the world. […]

October 15, 2020 - 3 minutesmins - By Helen Albert

News and Trends 14 Oct 2020

Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions

The Swedish firm Cartana and US-based ReadCoor have recently been snapped up by the US giant 10x Genomics to get hold of their spatial transcriptomics technology. What impact will these acquisitions have on the burgeoning field going forward? Last week, 10x Genomics took over ReadCoor for a smooth €298M ($350M). This followed the acquisition of […]

October 14, 2020 - 4 minutesmins - By Jonathan Smith

Expert Advice 14 Oct 2020

Everything You Need to Know About Biotech Business Models

What’s my business model? Who do I partner with? How do I scale up? These are typical strategic questions a young biotech will regularly face. The business model of a biotech company can determine its long-term trajectory to success. In this article, we’ll focus on a typical ‘platform’ biotech company in the biopharma sector whose […]

October 14, 2020 - 6 minutesmins - By External Contributor

News and Trends 9 Oct 2020

2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers

The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing tool, with the Nobel Prize in Chemistry awarded to two of its leading developers this week. The Prize in Chemistry went to Emmanuelle Charpentier, Director at the Max Planck Institute for Infection Biology in Berlin, and Jennifer Doudna, a Professor […]

October 9, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 7 Oct 2020

Investment Is Pouring Into Neuromodulation Treatments

The last month has seen several big investments in European neuromodulation and neurostimulation companies, which aim to treat neurological conditions by zapping nerve cells. What’s the reason for this funding peak? Last week, the Italian firm WISE announced the closing of a €15M Series C round to fund the development of a device that blocks […]

October 7, 2020 - 6 minutesmins - By Helen Albert

News and Trends 5 Oct 2020

Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection

The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the FDA’s rejection in August. What does this signal for Galapagos, Gilead, and other biotechs working in inflammatory disease? For Galapagos and Gilead, it’s been a rollercoaster few months. In August, the FDA decided against approving their drug filgotinib for treating […]

October 5, 2020 - 5 minutesmins - By Jonathan Smith

In Depth 5 Oct 2020

The Complications Around Patenting Biotechnology

Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field of intellectual property law: biotechnology patents. Back in 1873, microbiologist Louis Pasteur patented a new yeast-making […]

October 5, 2020 - 7 minutesmins - By External Contributor

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Bayer’s AskBio Acquisition Strong Statement For Gene Therapy in Europe

Universal Flu Vaccines Yield Second Clinical Failure This Year

Do Natural Killer Cells Hold the Key to Treating Blood Cancers?

How to Prepare for a Successful Biotech IPO

Top 10 Companies Combining AI and Drug Discovery in Europe

Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease

Spatial Transcriptomics Landscape Shifts With Two Major Acquisitions

Everything You Need to Know About Biotech Business Models

2020 Chemistry Nobel Prize Awarded to CRISPR-Cas9 Pioneers

Investment Is Pouring Into Neuromodulation Treatments

Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection

The Complications Around Patenting Biotechnology

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!